Literature DB >> 17032737

The nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in Drosophila.

Nikos Xylourgidis1, Peggy Roth, Nafiseh Sabri, Vasilios Tsarouhas, Christos Samakovlis.   

Abstract

CRM1-mediated protein export is an important determinant of the nuclear accumulation of many gene regulators. Here, we show that the NFkappaB transcription factor Dorsal is a substrate of CRM1 and requires the nucleoporin Nup214 for its nuclear translocation upon signaling. Nup214 bound to CRM1 directly and anchored it to the nuclear envelope. In nup214 mutants CRM1 accumulated in the nucleus and NES-protein export was enhanced. Nup214 formed complexes with Nup88 and CRM1 in vivo and Nup214 protected Nup88 from degradation at the nuclear rim. In turn, Nup88 was sufficient for targeting the complex to the nuclear pores. Overexpression experiments indicated that Nup214 alone attracts a fraction of CRM1 to the nuclear envelope but does not interfere with NES-GFP export. By contrast, overexpression of the Nup214-Nup88 complex trapped CRM1 and Dorsal to cytoplasmic foci and inhibited protein export and immune response activation. We hypothesize that variation in levels of the Nup214-Nup88 complex at the pore changes the amount of NPC-bound CRM1 and influences the relative strength and duration of NFkappaB signaling responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032737     DOI: 10.1242/jcs.03201

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  25 in total

Review 1.  The role of nuclear pores in gene regulation, development and disease.

Authors:  Maya Capelson; Martin W Hetzer
Journal:  EMBO Rep       Date:  2009-06-19       Impact factor: 8.807

Review 2.  Atomic basis of CRM1-cargo recognition, release and inhibition.

Authors:  Ho Yee Joyce Fung; Yuh Min Chook
Journal:  Semin Cancer Biol       Date:  2014-03-12       Impact factor: 15.707

Review 3.  Maternal control of the Drosophila dorsal-ventral body axis.

Authors:  David S Stein; Leslie M Stevens
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-05-29       Impact factor: 5.814

Review 4.  New targets for the antitumor activity of gambogic acid in hematologic malignancies.

Authors:  Li-jing Yang; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

5.  Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.

Authors:  Mourad Zerfaoui; Youssef Errami; Amarjit S Naura; Yasuhiro Suzuki; Hogyoung Kim; Jihang Ju; Tao Liu; Chetan P Hans; Jong G Kim; Zakaria Y Abd Elmageed; Shahriar Koochekpour; Andrew Catling; A Hamid Boulares
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

6.  Nucleoporin-Regulated MAP Kinase Signaling in Immunity to a Necrotrophic Fungal Pathogen.

Authors:  Bianca Genenncher; Lennart Wirthmueller; Charlotte Roth; Melanie Klenke; Liang Ma; Amir Sharon; Marcel Wiermer
Journal:  Plant Physiol       Date:  2016-09-02       Impact factor: 8.340

Review 7.  How do kidney cells adapt to survive in hypertonic inner medulla?

Authors:  Tomas Berl
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

8.  Nuclear pore complex component MOS7/Nup88 is required for innate immunity and nuclear accumulation of defense regulators in Arabidopsis.

Authors:  Yu Ti Cheng; Hugo Germain; Marcel Wiermer; Dongling Bi; Fang Xu; Ana V García; Lennart Wirthmueller; Charles Després; Jane E Parker; Yuelin Zhang; Xin Li
Journal:  Plant Cell       Date:  2009-08-21       Impact factor: 11.277

Review 9.  Nuclear pore proteins and cancer.

Authors:  Songli Xu; Maureen A Powers
Journal:  Semin Cell Dev Biol       Date:  2009-03-18       Impact factor: 7.727

10.  Tristetraprolin impairs NF-kappaB/p65 nuclear translocation.

Authors:  Yvonne M Schichl; Ulrike Resch; Renate Hofer-Warbinek; Rainer de Martin
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.